Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EndoPAT for Endothelial Dysfunction in ED and Hormonal Therapy
NCT06720597Recruiting
- Sponsor
- University of California, Irvine
- Start
- Aug 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of testosterone in erectile dysfunction (ED) and Hypogonadism (3 arms), sponsored by University of California, Irvine. Primary endpoint: Reactive Hyperemia Index at 6 months. Started Aug 2025; status: recruiting.
02
Drugs
testosterone
03
Conditions
erectile dysfunction (ED)Hypogonadism
Beyond the preview
Go deeper on NCT06720597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06720597.